HER2 Chimeric Antigen Receptor T Cell Immunotherapy Is an Effective Treatment for Diffuse Intrinsic Pontine Glioma

Scientists detected high HER2 cell surface protein across a panel of patient-derived diffuse intrinsic pontine glioma (DIPG) cells, thereby identifying an existing CAR T cell therapy for use in DIPG.